Fig. 5From: Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of AnthraxJ774A.1 cell survival with PA21 treatment. Serially diluted LF was incubated with PA83 and different concentrations of antibodies for 3 h. Through the AQ assay, cell viability was determined and plotted as the survival percentageBack to article page